Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

92828

registered interest
date	13/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 16 July 2014 to Question 204839, whether NHS England will publish the Innovation Health and Wealth refresh review before (a) 31 December 2014 and (b) 31 March 2015.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	210132
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>National Health Service England has advised that the publication of this review has been superseded by a five-year forward view of innovation, led by the national clinical director for innovation, which will be published shortly.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/10/2014 16:32:52 answering member 4020 label Biography information for George Freeman
tabling member	1604 label Biography information for Mr Virendra Sharma

92829

registered interest
date	13/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent discussions he has had with NHS England on assessment of dispensing appliance contractor licences on a national basis.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	210128
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>The Department sets the legislative framework for the inclusion of dispensing appliance contractors on National Health Service England pharmaceutical lists. It is up to NHS England to administer the Regulations and to monitor these contractors. It is for NHS England to approach the Department if they wish to discuss changes to the legislative arrangements. No such approach has been made.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/10/2014 16:34:38 answering member 4020 label Biography information for George Freeman
tabling member	1604 label Biography information for Mr Virendra Sharma

92830

registered interest
date	13/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Intellectual Property
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many items of intellectual property have been protected against exploitation; and what assessment he has made of the (a) financial and (b) other effects of the exploitation of intellectual property generated by National Institute of Health Research funding.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	210133
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>The Department’s National Institute for Health Research (NIHR) recognises the key role of Intellectual Property (IP) assets in driving innovation, and the importance of a range of associated activities such as fostering a culture of invention through to collaborating with industry. The NIHR standard research contract is worded to ensure appropriate exploitation of IP.</p><p> </p><p> </p><p> </p><p>For 2013-14, NIHR biomedical research centres and units reported a total of 98 patent applications granted, 106 licensing deals agreed, and 6 spin-off companies established.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/10/2014 16:50:17 answering member 4020 label Biography information for George Freeman
tabling member	1604 label Biography information for Mr Virendra Sharma

92831

registered interest
date	13/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Intellectual Property
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what effect the adoption of commercialised NHS intellectual property has had on (a) cost savings and (b) patient safety in each of the last five years.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	210129
answer	answer is ministerial correction date of answer 22/10/2014 answer text <p>Neither the Department nor NHS England has made any such assessment.</p><p> </p><p><strong> </strong></p><p> </p><p>We have been informed by NHS England that the cost of tracking the cost benefit of the adoption of every piece of intellectual property in the NHS would be excessive.</p><p> </p><p><strong> </strong></p><p> </p><p>The Department and NHS England have commissioned leading universities to assess the impact of <em>Innovation, Health and Wealth</em> on a range of measures, including value for money, patient outcomes and economic growth.</p><p> </p><p><strong> </strong></p><p> </p><p>In the meantime, the Innovation Scorecard monitors whether uptake and utility of innovations in the NHS is improving. Evidence suggests that steady growth is being achieved and the most recent information is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/searchcatalogue?productid=15598&amp;q=innovation+scorecard&amp;sort=Relevance&amp;size=10&amp;page=1#top" target="_blank">www.hscic.gov.uk/searchcatalogue?productid=15598&amp;q=innovation+scorecard&amp;sort=Relevance&amp;size=10&amp;page=1#top</a></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 210127 question first answered 22/10/2014 14:39:50 answering member 4020 label Biography information for George Freeman
tabling member	1604 label Biography information for Mr Virendra Sharma

92832

registered interest
date	13/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Intellectual Property
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of the commercialisation of intellectual property in the NHS since 2010.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	210127
answer	answer is ministerial correction date of answer 22/10/2014 answer text <p>Neither the Department nor NHS England has made any such assessment.</p><p> </p><p><strong> </strong></p><p> </p><p>We have been informed by NHS England that the cost of tracking the cost benefit of the adoption of every piece of intellectual property in the NHS would be excessive.</p><p> </p><p><strong> </strong></p><p> </p><p>The Department and NHS England have commissioned leading universities to assess the impact of <em>Innovation, Health and Wealth</em> on a range of measures, including value for money, patient outcomes and economic growth.</p><p> </p><p><strong> </strong></p><p> </p><p>In the meantime, the Innovation Scorecard monitors whether uptake and utility of innovations in the NHS is improving. Evidence suggests that steady growth is being achieved and the most recent information is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/searchcatalogue?productid=15598&amp;q=innovation+scorecard&amp;sort=Relevance&amp;size=10&amp;page=1#top" target="_blank">www.hscic.gov.uk/searchcatalogue?productid=15598&amp;q=innovation+scorecard&amp;sort=Relevance&amp;size=10&amp;page=1#top</a></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 210129 question first answered 22/10/2014 14:39:50 answering member 4020 label Biography information for George Freeman
tabling member	1604 label Biography information for Mr Virendra Sharma

92834

registered interest
date	13/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Intellectual Property
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether the new Academic Health Science Networks contract with NHS England includes responsibility for identification, protection and exploitation of intellectual property support for local NHS organisations.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	210124
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>Although Academic Health Science Networks (AHSNs) may offer support to National Health Service organisations in identification, protection and exploitation of intellectual property, it is not an explicit requirement of the contract that they do so. <br> <br> AHSNs are responsible for identifying local priorities for driving patient-based research, improvement pathway, inward investment and life science income based upon local need and by drawing upon local opportunities, resources and expertise within their networks. It is for AHSNs to determine how they can best deliver upon these objectives.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/10/2014 16:23:47 answering member 4020 label Biography information for George Freeman
tabling member	1604 label Biography information for Mr Virendra Sharma

92835

registered interest
date	13/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Intellectual Property
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 14 July 2014 to Question 204182, what the reason is for the time taken to publish the intellectual property review.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	210176
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>National Health Service England advises that work is needed to ensure that the intellectual property review reflects the new NHS landscape. This work is currently underway and being led by the national clinical director for innovation.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/10/2014 16:30:57 answering member 4020 label Biography information for George Freeman
tabling member	1604 label Biography information for Mr Virendra Sharma

92836

registered interest
date	13/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Intellectual Property
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 14 July 2014 to Question 204180, on the basis of what information NHS England and his Department established that local commissioners are fulfilling the assessment of providers passing or failing the Commissioning for Quality and Innovation pre-qualification thresholds in 2012-13 and 2013-14; and whether that information will be published.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	210175
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>The arrangements for Commissioning for Quality and Innovation (CQUIN) pre-qualification reporting are a matter for the clinical commissioning groups and area teams. We understand that National Health Service England does not capture any data centrally on whether providers were assessed to have met (or not met) the pre-qualification criteria which have been part of previous national CQUIN schemes.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/10/2014 16:29:26 answering member 4020 label Biography information for George Freeman
tabling member	1604 label Biography information for Mr Virendra Sharma

92838

registered interest
date	13/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Incontinence: Products
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will make an assessment of the difficulties created by users of continence products by the practices from wholesalers and the introduction of off script supply and formularies.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	210134
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>Under the current legislative framework, continence products are supplied by pharmaceutical services providers, including pharmacists, dispensing appliance contractors and dispensing doctors in response to a National Health Service prescription. Part IX of the Drug Tariff sets out the products that general practitioners can prescribe on an NHS prescription in primary care. If there are local arrangements outside of these national arrangements, it would be for local commissioners as part of their commissioning process to assess the suitability of these arrangements.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 21/10/2014 16:30:30 answering member 4020 label Biography information for George Freeman
tabling member	1604 label Biography information for Mr Virendra Sharma

92839

registered interest
date	13/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS Accelerator Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 14 July 2014 to Question 204192, for what reason the NHS Accelerator Fund is NHS branded without the involvement of his Department and NHS England.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	210174
answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>We understand that the National Health Service Accelerator Fund has become a working title for a potential fund to support innovations in the NHS. However as the fund has not been launched or any money raised, there is no formal entity in place with this official title. Any proposal to launch the fund with NHS as part of its title would be subject to normal consideration under NHS brand rules.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/10/2014 16:51:29 answering member 4020 label Biography information for George Freeman
tabling member	1604 label Biography information for Mr Virendra Sharma